Upload
marcus-evans
View
112
Download
0
Embed Size (px)
Citation preview
Monetizing
Your Company’s
Litigation Assets
CORPORATE CLASS ACTION, OPT-OUTS, AND PRIVATE LITIGATION
Major corporations serving as class representatives in successful antitrust class actions:
Credit card services. Walmart, Sears, Safeway and others: In re Visa Check/Mastermoney
Antitrust Litig., 280 F.3d 124 (2d Cir. 2010).
Large and small merchants, and three trade associations alleged illegal tying of credit
and debit card services and attempted monopolization of the debit card market.
Corn syrup. H.J. Heinz, Coca Cola Co., PepsiCo, Kraft Foods Inc. and others: In re High
Fructose Corn Syrup Antitrust Litig., 156 F. Supp.2d 1017 (C.D. Ill. 2001), aff’d 295 F.3d 651 (7th
Cir. 2002).
Purchasers of high fructose corn syrup alleged a price fixing conspiracy.
Corporations Serving as Class
Representative in Antitrust Actions
Corporations Serving as Class Representative in Antitrust Actions (cont’d)
Smaller corporations also serve as class representatives:
Vitamin C. In re Vitamin C Antitrust Litig., 2012 WL 251909 (E.D.N.Y. 2012).
Corporate plaintiffs alleged a price fixing conspiracy, with a damages class and an
injunctive relief class.
Flat Panel Displays. In re TFT/Flat Panel Display Antitrust Litig., No. M 07-1827 SI, MDL No. 1827
(N.D. Cal. Mar. 28, 2010).
Direct purchasers of flat panels and/or direct purchasers of products containing flat
panels alleged a price fixing conspiracy.
Corporations Serving as Class Representative in Antitrust Actions
(cont’d)
Chemical components. In re Vitamins Antitrust Litig., 209 F.R.D. 251 (D.D.C. 2002).
Direct purchasers alleged that the defendant manufacturers conspired to fix prices for
vitamins and vitamin components.
Cardboard boxes. Kleen Products LLC v. International Paper, Case No. 1:10-cv-05711(N.D.
Ill. 2010).
Direct purchasers of corrugated sheets and containers allege a conspiracy to reduce
inventory and raise prices.
Citric acid. In re Citric Acid Antitrust Litig., 1996 WL 655791 (N.D. Cal. Oct. 2, 1996), aff’d on
other grounds 191 F.3d 1090 (9th Cir. 1999).
Direct purchasers of citric acid alleged a price fixing conspiracy that affected all forms
of citric acid in all purchasing situations.
My case: News America Marketing
The Dial Corporation, et al. v. News Corporation, et al., Civ. Action No.
13-CV-06802 (S.D.N.Y) (Judge Pauley)
Six corporate class representatives
HP Hood LLC
Dial Corporation/Henkel Consumer Goods Inc.
Foster Poultry Farms
BEF Foods Inc.
Kraft Heinz Foods Co.
Smithfield Foods, Inc.
News America Marketing Case
Filed in December 2013
Product at issue: In-Store Promotions (at shelf advertising) in grocery
stores and drug stores
Conduct at issue: Monopolization of In-store Promotion market
Amount of overcharge: between $230 and $446 million
News America Marketing Case –
Conduct at Issue Exclusive, Long-Term, and Staggered Lease Contracts with
Retailers That Block Competitors’ Access to 85% of Available In-
Store Promotion Space and Limit Annual Opportunities for
Competitor Entry
Use of Large Cash Payments with Retailers to Exclude In-Store Competitors (Floorgraphics, Insignia, Valassis)
Exclusive, Long-Term and ROFR Sales Contracts with Consumer
Packaged Goods Companies for In-Store Promotion Services
News America Marketing Case –
Conduct at Issue (cont’d)
Acquisitions of Competitors (ActMedia (1997) and Floorgraphics
(2009))
Removal of Competitor Products from Stores
Hacking of Competitor Computer Systems and Stealing Data
Prior successful actions by competitors laid groundwork for customer
claims
Damages Settled on first day of trial for $244 million and various forms
of injunctive relief
400 claimants recovered in excess of single damages –
approximately 10 cents back for every dollar spent on the
in-store marketing services after fees and expenses
Hood’s Recovery: $1.809 million in damages and $50,000
incentive fee
We also recovered approximately $250K in fees we had
agreed to front
Costs of Being a Class
Representative
Litigation fees and costs, unless taken on full
contingency
Document discovery
Depositions
Publicity
Benefits of Being a Class
Representative
Being able to control your own litigation
Recovering legal fees and costs
Seeking incentive fees
Making a statement to future antitrust violators
Building relationships with other companies and counsel
Direct v. Indirect Claims for Antitrust
Violations
Under the U.S. Supreme Court’s Illinois Brick decision, only
direct purchasers (e.g., wholesalers, retailers) may bring
private Sherman Act damage claims
Twenty-eight states have enacted “Illinois Brick
Repealer” statutes allowing indirect purchasers (end
payors, i.e., retailers, consumers) to sue for damages
under state antitrust law
Direct v. Indirect Claims for
Antitrust Violations (cont’d) Indirect purchaser claims subject to a pass-on defense: no recovery
to the extent plaintiff passed on the overcharge to the next
purchaser
Total indirect purchaser damages cannot exceed the total
overcharge; some states have damage trebling, some do not
Indirect claims must be brought in state court unless there is (a)
complete diversity, or (b) a federal claim (e.g., direct purchaser claim) to which they can be pendent
Pharmaceutical cases where direct
purchaser classes have produced
more significant settlements than end
payor classes
Case Name Direct Purchaser
Class Settlement
End Payor Class
Settlement
Settlement Date
King Drug Co. v. Cephalon (Provigil)
$512,000,000 No settlements
4/20/15
In re Skelaxin (Metaxalone)
Antitrust Litig. $73,000,000 $2,000,000 6/30/14
In re Flonase Antitrust Litig. $150,000,000 $35,000,000 6/14/13
In re Wellbutrin SR Antitrust Litig.
$49,000,000 $21,500,000 11/21/11
Meijer, Inc. v. Abbott Labs. (Norvir)
$52,000,000 $10,000,000 8/11/11
In re Tricor Direct Purchaser Antitrust Litig.
$250,000,000 $65,700,000 4/23/09
End Payor Class Recovery Challenges
Perception that federal cases often are
stronger and simpler (hence attracting
stronger class counsel)
Tougher class certification hurdles for end
payor classes - class counsel often take
lower settlements
End Payor Class Recovery
Challenges
Challenge securing class reps from every repealer state
reduces viable state claims
There have been some bad class certification decisions
in pharmaceutical cases that create challenges for
those types of actions
But these factors do not apply to opt-out end
payor plaintiffs
What is an Opt-Out?
“opt-out”: to choose not to participate in
(something); to decide not to be part of a
group or system “with so many plaintiffs opting
out of the class, the defendant braced itself for
multiplicitous lawsuits.” Black's Law Dictionary (10th ed.
2014)
Civil Litigation Opt-Out
In civil litigation, an “opt-out” is a company that chooses
to opt-out of a certified class
Timing: at any point after a class action complaint is
filed and before the opt-out deadline in the class notice
Damages
Evidence from recent price-fixing cases:
anticompetitive conduct caused the prices to be
at least 10 % to 20 % higher than what they would
have been in the absence of collusion.
Examples from the Headlines
“Jury Awards Costco $110 Million in LCD Price-Fixing Trial”
In the cartel class action against the manufacturers of liquid-crystal-display (LCD) panels, more than 75 companies—including Apple, Best Buy, Dell, Costco, and Kodak—opted out and pursued direct recovery through individual actions.
“Google Sues Visa, MasterCard after Opting Out of $5.7B Antitrust Settlement.” Google, Inc. v.
Visa, Inc., No. 15-cv-00197 (E.D.N.Y.) Settled on January 30th, 2015, a month after it was filed.
Example of opt-out plaintiffs doing well
In the Remeron Antitrust Litigation, a pharmaceuticals case, nine opt-out retailers (suing via assignment from direct purchaser wholesalers) settled their claims for $59.8 million
Health insurance companies have started
opting out of pharmaceutical cases
Case Opt-out plaintiffs from end payor classes
In re Lidoderm Antitrust Litig. Government Employees Health Association (GEHA)
(pending)
In re Aggrenox Antitrust Litig.
Humana Inc., Louisiana BCBS
(pending)
In re Nexium (Esomeprazole)
Antitrust Litig.
Humana Inc., Cariten Ins. Co., Emphesys, Insurance
Co., M.D. Care Inc., CHA HMO, Inc., Careplus Health
Plans, Inc., Arcadian Health Plan, Inc.
In re Neurontin Marketing and
Sales Practices Litig.
Kaiser Foundation Health Plan, Inc. and Kaiser
Foundation Hospitals, Aetna, Inc.
In re Flonase Antitrust Litig. Blue Cross and Blue Shield affiliates
In re Lorazepam and
Clorazepate Antitrust Litig.
BCBS MA, BCBS MN, Federated Mutual Ins. Co.,
Health Care Service Corp.
Checklist for Potential Opt-Outs
Step 1: Monitoring for New Class Actions
Step 2: Identifying Potential Opt-Out Opportunities
Potential damages – trade spend?
Strategic business relationships?
Strength of legal claims?
Step 3: Deciding Whether to Opt Out of the Class
Step 4: Weighing the Timing of the Opt-Out Decision
Source: Charles H. Samel and Cori Gordon Moore, Whether to Opt Out of
Antitrust Class Actions: A Four-Step Checklist, ABA Section of Litigation,
Corporate Counsel Newsletter (May 26, 2015)
Benefits of Not Opting Out of the Class
No risk: If you opt-out, you bear the risk of litigation for
single claim
Anonymity: If you opt-out and proceed on your own, you would lose the anonymity afforded by the class action
Opt-out actions can be expensive
Legal fees of class counsel : some courts require opt-outs to pay a portion of class counsel fees to avoid “free riders”
Source: Gregory Asciolla and Bernard Persky, The Advantages of Not Opting Out of Class Action Litigation, Antitrust Counselor, (February 1, 2008)
DuPont turns its law department
into a profit center
Years ago, DuPont formalized what it called a “legal
recovery program” in order “to proactively assert the
company’s rights by recovering lost value which can
positively contribute to profitability.” LexisNexis, The Profitable Legal
Department—How Legal Departments Can Prosper by Generating Revenue for Their
Company—2010 Research Report 10.
Between 2004 and 2008, DuPont reported more than $1
billion in total recoveries, some of which resulted from
antitrust litigation. Id. at 9–10.
Develop a systematic approach
to analyze each potential case
Allows CLO to pick and choose when to opt-out of cases
and when to stay in a putative class
Facilitates identification of high-value cases (strong on
liability, causation, and damages) as to which company
may want to pursue its own action
This strategy has been successfully implemented by drug
stores, grocery stores and large corporations in other
industries affected by antitrust violations
Actions to turn your law
department into a profit center
Do you have a market that is affected by exclusionary conduct?
Can be an input market, a market that your company competes in or a
market that services your company, i.e. in-store marketing
Review purchase agreements and purchasing records
Retain experienced outside antitrust counsel
Interview purchasing officers regarding market dynamics
Reach out to competitors (with care)
Draft Complaint
Retain expert to refine damages calculations
Three principal litigation
options
1. Do nothing, remain in any certified classes, and
apply for any available claims money
or
2. Opt out of direct class and litigate any available
direct claims and/or
3. Opt out of end payor class and litigate any available
state law indirect purchaser claims
Option #1: Do nothing
If no class certified, zero recovery
End payor class settlements likely to be
relatively small compared to direct
purchasers
Some large claimants have inserted
themselves into the class settlement
process, which sometimes may result in a
larger share of a small class settlement
Option #2: Pursue potential direct
claims
Assess amount of direct buys at-issue
Is it feasible to obtain assignments from wholesalers?
If assignments obtained for all indirect purchases, possible
to make a direct claim for 100% of purchases nationwide
Under federal law, there is no pass-on defense and all proven damages are automatically trebled
(a) potential direct buys;
(b) via assignment from wholesalers
Option #3: Pursue indirect claims
under available state laws
Twenty-eight states have antitrust or
consumer protection laws that permit
indirect purchasers to recover damages
AL, AZ, CA, DC, FL, HI, IL, IA, KS, ME,
MA, MI, MN, MS, NE, NV, NH, NM, NY,
NC, ND, OR, SD, TN, UT, VT, WV, WI
Some of these states also allow treble
damages
Potential Suit:
Individual or Joint Action
Possible litigation options:
Sue individually as a direct purchaser
Sue jointly with one or more other similarly situated direct-purchaser
companies
Sue in parallel with one or more competitors
Enter into tolling agreement with potential defendants while preparing for
one or more of the above options
Single Damages
A corporate plaintiff can potentially recover tens or even hundreds
of millions of dollars in damages through settlement or trial.
Usually 10% to 30% of expenditures on the products in antitrust cases
Can be more, can be less
Damage period (federal actions): four years which continues after
complaint is filed
Settlements are typically single damages or a fraction thereof
News America Marketing settlement: clients are recovering
approximately 10 cents back for every dollar they spent on the products
Treble Damages if you go all the
way
Potential for treble damages with a jury verdict
E.g., with a 30% overcharge and treble damages, for each $1 million
that your company spends, overcharge damages at trial could be
trebled to as high as 90% or $900,000
Settlements are typically single damages or a fraction thereof
Cases that went all the way to treble damages
Moist snuff. $350 million, trebled to $1.05 billion. Conwood v. US Tobacco, 290
F.3d 768 (6th Cir. 2002).
Urethanes. $400 Million. Trebled to $1.2 Billion. In re: Urethane Antitrust
Litigation, Case No. 2:04-md-01616 (D. Kan.)
Terms of Representation
Outside counsel are generally flexible as to hybrid or fully contingent
representation
In large hybrid or fully contingent cases, outside counsel typically
work with other law firms, to share resources and risk
Resource commitment
Company to commit sporadic time of in-house counsel and purchasing
officer(s) or others with plenty of advance notice
Discovery obligations (document and deposition)